Lincoln, NE – 2/17/2025 HTI Plastics, a global leader in custom and proprietary injection molded plastic pharmaceutical components, is pleased to announce its participation in DCAT Week 2025, taking place March 17-20 in New York City.  This marks HTI’s second consecutive year attending the prestigious event, reinforcing our commitment to innovation and excellence in pharmaceutical manufacturing.

With decades of experience and expertise spanning operations, engineering, quality and beyond, HTI Plastics is dedication to delivering high-quality solutions to the pharmaceutical industry.  HTI holds ISO 13485 and ISO 9001 certifications, as well as holding a MDR certification, ensuring compliance with the most rigorous industry standards.

“We are excited to be attending DCAT Week once again,” said John Eby, Director of Sales and Marketing at HTI Plastics. “This event provides an invaluable opportunity to connect with current customers and engage with new prospects from around the world. It allows us to showcase our expertise in pharmaceutical injection molding and explore how we can support the evolving needs of the industry.”

DCAT Week is a premiere global event for the pharmaceutical industry, bringing together top manufacturers, suppliers, and key decision-makers.  HTI Plastics invites companies interested in custom pharmaceutical injection molding solutions to connect with us during the event.  To schedule a meeting with HTI Plastics at DCAT Week, please contact us at jeby@htiplastic.com.